UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 37

Sortiert nach

Retinoic acid receptor β2 agonists restore glycaemic control in diabetes and reduce steatosis

Diabetes, obesity & metabolism, 2016-02, Vol.18 (2), p.142-151

2016

Volltextzugriff (PDF)

Retinoic acid receptor [beta]2 agonists restore glycaemic control in diabetes and reduce steatosis

Diabetes, obesity & metabolism, 2016-02, Vol.18 (2), p.142

2016

Volltextzugriff (PDF)

A role for retinoids in the treatment of COVID‐19?

Clinical and experimental pharmacology & physiology, 2020-10, Vol.47 (10), p.1765-1767

Trasino, Steven E.

2020

Volltextzugriff (PDF)

Remission of Type 2 Diabetes with Very Low-Calorie Diets-A Narrative Review

Nutrients, 2021-06, Vol.13 (6), p.2086

2021

Volltextzugriff (PDF)

mTOR1c Activation with the Leucine "Trigger" for Prevention of Sarcopenia in Older Adults During Lockdown

Journal of medicinal food, 2022-02, Vol.25 (2), p.117

2022

Volltextzugriff (PDF)

Effects of AM80 compared to AC261066 in a high fat diet mouse model of liver disease

PloS one, 2019-01, Vol.14 (1), p.e0211071

2019

Volltextzugriff (PDF)

Obesity Leads to Tissue, but not Serum Vitamin A Deficiency

Scientific reports, 2015-11, Vol.5 (1), p.15893-15893, Article 15893

2015

Volltextzugriff (PDF)

Vitamin A Deficiency Causes Hyperglycemia and Loss of Pancreatic β-Cell Mass

The Journal of biological chemistry, 2015-01, Vol.290 (3), p.1456-1473

2015

Volltextzugriff (PDF)

Prenatal Choline Supplementation Improves Glucose Tolerance and Reduces Liver Fat Accumulation in Mouse Offspring Exposed to Ethanol during the Prenatal and Postnatal Periods

Nutrients, 2024-04, Vol.16 (9), p.1264

2024

Volltextzugriff (PDF)

A retinoic acid receptor β2 agonist reduces hepatic stellate cell activation in nonalcoholic fatty liver disease

Journal of molecular medicine (Berlin, Germany), 2016-10, Vol.94 (10), p.1143-1151

2016

Volltextzugriff (PDF)

Retinoids in the Pathogenesis and Treatment of Liver Diseases

Nutrients, 2022-03, Vol.14 (7), p.1456

2022

Volltextzugriff (PDF)

Retinoic Acid Receptor β Loss in Hepatocytes Increases Steatosis and Elevates the Integrated Stress Response in Alcohol-Associated Liver Disease

International journal of molecular sciences, 2023-07, Vol.24 (15), p.12035

2023

Volltextzugriff (PDF)

A retinoic acid receptor beta 2 agonist reduces hepatic stellate cell activation in nonalcoholic fatty liver disease

Journal of molecular medicine (Berlin, Germany), 2016-10, Vol.94 (10), p.1143-1151

2016

Volltextzugriff (PDF)

Fenretinide Improves Intestinal Barrier Function and Mitigates Alcohol Liver Disease

Frontiers in pharmacology, 2021-03, Vol.12, p.630557-630557

2021

Volltextzugriff (PDF)

Success and failures of telehealth during COVID‐19 should inform digital applications to combat obesity

Obesity science & practice, 2022-04, Vol.8 (2), p.254-258

2022

Volltextzugriff (PDF)

Fenretinide Reduces Intestinal Mucin-2-Positive Goblet Cells in Chronic Alcohol Abuse

Pharmacology, 2022-07, Vol.107 (7-8), p.1-416

2022

Volltextzugriff (PDF)

Mycobacterium tuberculosis infection is exacerbated in mice lacking lecithin:retinol acyltransferase

Biochimica et biophysica acta. Molecular basis of disease, 2020-11, Vol.1866 (11), p.165909-165909, Article 165909

2020

Volltextzugriff (PDF)

A retinoic acid receptor β2 agonist protects against alcohol liver disease and modulates hepatic expression of canonical retinoid metabolism genes

BioFactors (Oxford), 2022-03, Vol.48 (2), p.469-480

2022

Volltextzugriff (PDF)

Pregnancy and neonatal outcomes among a cohort of HIV-infected women in a large Italian teaching hospital: a 30-year retrospective study

Epidemiology and infection, 2017-06, Vol.145 (8), p.1658-1669

2017

Volltextzugriff (PDF)

Ligand, receptor, and cell type–dependent regulation of ABCA1 and ABCG1 mRNA in prostate cancer epithelial cells

Molecular cancer therapeutics, 2009-07, Vol.8 (7), p.1934-1945

2009

Volltextzugriff (PDF)

Obesity Leads to Tissue, but not Serum Vitamin A Deficiency

The FASEB journal, 2017-04, Vol.31 (S1)

2017

Volltextzugriff (PDF)

A retinoic acid receptor [beta]2 agonist reduces hepatic stellate cell activation in nonalcoholic fatty liver disease

Journal of molecular medicine (Berlin, Germany), 2016-10, Vol.94 (10), p.1143

2016

Volltextzugriff (PDF)

Feeding probiotic Lactobacillus paracasei to Ossabaw pigs on a high-fat diet prevents cholesteryl-ester accumulation and LPS modulation of the Liver X receptor and inflammatory axis in alveolar macrophages

The Journal of nutritional biochemistry, 2013-11, Vol.24 (11), p.1931-1939

2013

Volltextzugriff (PDF)

Retinoic Acid Receptor β2 Agonists Restore Glycemic Control In Diabetes and Reduce Steatosis

Diabetes, obesity & metabolism, 2015-12, Vol.18 (2), p.142-151

2015

Volltextzugriff (PDF)

Androgen Regulation of Aldehyde Dehydrogenase 1A3 (ALDH1A3) in the Androgen-Responsive Human Prostate Cancer Cell Line LNCaP

Experimental biology and medicine (Maywood, N.J.), 2007-06, Vol.232 (6), p.762-771

2007

Volltextzugriff (PDF)

1 – 25 von 37

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(36)
Dissertationen
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Retinoic acid receptor β2 agonists restore glycaemic control in diabetes and reduce steatosis

Retinoic acid receptor [beta]2 agonists restore glycaemic control in diabetes and reduce steatosis

A role for retinoids in the treatment of COVID‐19?

Remission of Type 2 Diabetes with Very Low-Calorie Diets-A Narrative Review

mTOR1c Activation with the Leucine "Trigger" for Prevention of Sarcopenia in Older Adults During Lockdown

Effects of AM80 compared to AC261066 in a high fat diet mouse model of liver disease

Obesity Leads to Tissue, but not Serum Vitamin A Deficiency

Vitamin A Deficiency Causes Hyperglycemia and Loss of Pancreatic β-Cell Mass

Prenatal Choline Supplementation Improves Glucose Tolerance and Reduces Liver Fat Accumulation in Mouse Offspring Exposed to Ethanol during the Prenatal and Postnatal Periods

A retinoic acid receptor β2 agonist reduces hepatic stellate cell activation in nonalcoholic fatty liver disease

Retinoids in the Pathogenesis and Treatment of Liver Diseases

Retinoic Acid Receptor β Loss in Hepatocytes Increases Steatosis and Elevates the Integrated Stress Response in Alcohol-Associated Liver Disease

A retinoic acid receptor beta 2 agonist reduces hepatic stellate cell activation in nonalcoholic fatty liver disease

Fenretinide Improves Intestinal Barrier Function and Mitigates Alcohol Liver Disease

Success and failures of telehealth during COVID‐19 should inform digital applications to combat obesity

Fenretinide Reduces Intestinal Mucin-2-Positive Goblet Cells in Chronic Alcohol Abuse

Mycobacterium tuberculosis infection is exacerbated in mice lacking lecithin:retinol acyltransferase

A retinoic acid receptor β2 agonist protects against alcohol liver disease and modulates hepatic expression of canonical retinoid metabolism genes

Pregnancy and neonatal outcomes among a cohort of HIV-infected women in a large Italian teaching hospital: a 30-year retrospective study

Ligand, receptor, and cell type–dependent regulation of ABCA1 and ABCG1 mRNA in prostate cancer epithelial cells

Obesity Leads to Tissue, but not Serum Vitamin A Deficiency

A retinoic acid receptor [beta]2 agonist reduces hepatic stellate cell activation in nonalcoholic fatty liver disease

Feeding probiotic Lactobacillus paracasei to Ossabaw pigs on a high-fat diet prevents cholesteryl-ester accumulation and LPS modulation of the Liver X receptor and inflammatory axis in alveolar macrophages

Retinoic Acid Receptor β2 Agonists Restore Glycemic Control In Diabetes and Reduce Steatosis

Androgen Regulation of Aldehyde Dehydrogenase 1A3 (ALDH1A3) in the Androgen-Responsive Human Prostate Cancer Cell Line LNCaP

Suchergebnisse filtern